2015
DOI: 10.1097/mib.0000000000000477
|View full text |Cite
|
Sign up to set email alerts
|

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease

Abstract: Inflammatory bowel diseases (IBD) include ulcerative colitis and Crohn's disease. The immune response in ulcerative colitis is different from the Crohn's disease. Accumulating evidence suggests that IBD results from an inappropriate inflammatory response to intestinal microbes in a genetically susceptible host. Several immunoregulatory abnormalities have been reported in patients with IBD, including the ratio of proinflammatory (tumor necrosis factor alpha, IL-6, IL-1-β) to immunoregulatory cytokines (IL-10, T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
54
0
6

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 91 publications
(61 citation statements)
references
References 55 publications
1
54
0
6
Order By: Relevance
“…The interactions between these and other cells present in the inflamed mucosa are mediated by various cytokines including both pro‐inflammatory and anti‐inflammatory cytokines. It is widely known that IL‐10 can antagonize Th1 cytokines and stabilize intestinal mucosal immune balance, serving as an important anti‐inflammatory cytokines which plays a protective role in the development of IBD . Our data demonstrated that IL‐10 was up‐regulated after the treatment of IL‐35 recombinant protein.…”
Section: Discussionmentioning
confidence: 52%
“…The interactions between these and other cells present in the inflamed mucosa are mediated by various cytokines including both pro‐inflammatory and anti‐inflammatory cytokines. It is widely known that IL‐10 can antagonize Th1 cytokines and stabilize intestinal mucosal immune balance, serving as an important anti‐inflammatory cytokines which plays a protective role in the development of IBD . Our data demonstrated that IL‐10 was up‐regulated after the treatment of IL‐35 recombinant protein.…”
Section: Discussionmentioning
confidence: 52%
“…ILVs are formed by invagination of the limiting membrane of late endosome, which are then termed MVBs. After intracellular trafficking, MVBs dock at and subsequently fuse with plasma membrane, leading to the excretion of ILVs as exosomes . MVBs could also be targeted to lysosomes for degradation of their internal vesicles.…”
Section: Exosome Characterization and Involvement In Intestinal Mucosmentioning
confidence: 99%
“…The crucial role of T regulatory (Treg) cells in maintaining immune tolerance and restraining immune response from excessive amplification is well accepted. Treg cells exert their suppressive function mainly through cytokines secretion, including IL‐10, TGF‐β and IL‐35, or in a cell contact‐dependent manner . Increased apoptosis and deficiency of Treg cells had been observed in active IBD patients, which could be reversed by anti‐TNFα treatment.…”
Section: Exosome‐mediated Immunosuppression Of Treg Cellsmentioning
confidence: 99%
“…The Th1 pattern inflammation of IBD is featured as over production of Th1 cytokines, such as interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-176. Some ulcerative colitis is featured as a Th2 pattern inflammation, in which high levels of Th2 cytokines play a major role in the inflammation of the colon mucosa7.…”
mentioning
confidence: 99%